TP53 and cancer: HDACi-mediated cell death induction was thereby found to correlate with their ability to reduce mutant p53 expression and to inhibit ERK phosphorylation as well as c-MYC expression presumably via acetylation; ERK-mediated stabilization of the oncogenic protein c-MYC has been previously known to activate cell proliferation and mediate a pro-survival pathway in cancer cells.